Evaluation of clinical efficacy in patients with nonvalvular atrial fibrillation VKORC1 and CYP2C9 gene polymorphism Warfarin anticoagulation dose model

doi:10.3969/j.issn.1672-5301.2016.07.017

Home>Articles>Evaluation of clinical efficacy in patients with nonvalvular atrial fibrillation VKORC1 and CYP2C9 gene polymorphism Warfarin anticoagulation dose model

DOI: 10.3969/j.issn.1672-5301.2016.07.017

Evaluation of clinical efficacy in patients with nonvalvular atrial fibrillation VKORC1 and CYP2C9 gene polymorphism Warfarin anticoagulation dose model

Keywords：Gene polymorphismWarfarinAtrial fibrillation

Publication Date：2016-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 639-642 )

Chinese Journal of Cardiovascular Research

ISTIC

ISSN：1672-5301

Year, Vol.(Issue)：2016,14(7)